News

ARS Pharma plans to submit data from the repeat dose study of neffy to the FDA early in the second quarter of 2024, as part of its response to the CRL issued by the federal agency for the previously submitted New Drug Application (NDA).

No concerning patterns of long-term or increasing opioid use were observed within 3 years after first opioid prescription in opioid-naive children with SCD.

How effective can wearable technology with features designed for adults be for children when it comes to arrhythmias? Scott Ceresnak, MD, helps provide the answer in this Contemporary Pediatrics interview.

Microalbuminuria and low body iron levels displayed a significant association with pediatric hearing loss independently.

Procalcitonin can be useful for point-of-care testing in patients with influenza-like illness and a prolonged fever, guiding the indication for a chest radiograph while helping to avoid radiation exposure.

Hearing loss was more prevalent among children and adults with sickle cell disease and its traits compared to matched controls with normal hemoglobin.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

The approval makes omalizumab the first and only FDA-approved medicine to reduce allergic reactions in patients with one or more food allergies.

The Orphan Drug Designation follows the receipt of Rare Pediatric Disease Designation from the FDA in January 2024.

Promoting mental health and implementing stress-reducing scenarios for adolescents could lessen motivating factors for substance use.

Results demonstrated that foster care involvement does vary based on age and sex, with Black youths and females disproportionately effected.

The sNDA submission follows additional positive topline data that was presented in Janurary 2024, highlighting an open-label, long-term extension study evaluating tapinarof cream, 1%.

Compared to children with no maternal tobacco usage during pregnancy, those exposed had associations to childhood neurocognition deficits.

The review and meta-analysis reaffirmed previous data regarding maternal asthma and neonatal outcomes while also uncovering several novel findings.

Discover how recent research unveils the potential of psychological interventions in alleviating asthma attacks and mitigating associated psychological stressors, shedding light on promising avenues for asthma management.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

The twice-daily oral corticosteroid is indicated for 12 weeks of treatment.

Contemporary Pediatrics editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights our special nutrition issue, published for January/February, 2024.

Discover effective counseling techniques and overcome barriers to empower adolescents in making informed decisions about contraception, fostering trust, confidentiality, and autonomy in reproductive health care.

The child was otherwise healthy with no prior severe medical issues, and he did not present with COVID-19 symptoms. Can you diagnose this child based on the case below?

Joshua Feder, MD, explains how developmental care models for autism care can benefit children with autism, providers, parents, and other family members.

Samantha Olson, MPH, explains the important role of a strong recommendation for maternal influenza vaccination.

Deborah Persaud, MD, details results from her study that aimed to reduce HIV reservoirs in neonates with very early antiretroviral therapy.

Read the case and take your best guess at diagnosing this 4-year-old patient.

Weight can mean a lot of things. Context is important, and different measurements are used for specific goals.

Samantha Olson, MPH, breaks down a study highlighting the effectiveness of maternal influenza vaccination and its respective association with influenza-related hospitalizations in infants.

Investigators recently noted that despite a decrease in adolescent hospital visits during the height of the pandemic, there was an increase in sexually transmitted infections (STIs) in this population group.